13 / 154
Speaker’s Biographies
Research Fellowship – Senior Adult Oncology Department – 2013/2014 Thomas Jefferson University Hospitals –
Philadelphia, USA
Speaker Abstract(s): S24, S25
Lalit Krishna
Deputy Program Director, Duke-NUS Practice Course Year 2 (Professionalism and Ethics)
,
Assistant Professor, Duke-
NUS Graduate Medical School Singapore, Assistant UG Curriculum Director (Clinical), Centre of Biomedical Ethics at
NUS, Palliative Medicine, Singapore, Singapore
Dr Lalit Krishna, MB ChB (Liverpool), FRCP Edin, FAMS, MA (Ethics), MA (Med Edu), PhD (Spore), is a Senior
Consultant at the Division of Palliative Medicine, National Cancer Centre. He holds a Masters in Medical Ethics and
Masters in Medical Education as well as a PhD in Medical Ethics.
Dr Lalit Krishna also holds the appointments of Assistant Professor at Duke-NUS Graduate Medical School Singapore,
and Clinical Senior Lecturer at Yong Loo Lin School of Medicine, National University of Singapore. He has recently
taken up the post of co-Director of Practice Course 2 at Duke NUS and Assistant UG Curriculum Director (Clinical) at
the Centre of Biomedical Ethics at NUS. He is the chairman of the Clinical Ethics Committee and the Internal Audit
Committee at NCCS. He is actively involved in teaching and presently undertaking a PhD in Medical Education.
Speaker Abstract(s): S26, S27
Ian Kunkler
University of Edinburgh, Oncology, Edinburgh, UK
Professor Ian Kunkler
(www.iankunkler.org.uk) is Consultant and Honorary Professor in Clinical Oncology at
the Edinburgh Cancer Centre, University of Edinburgh. He qualified in Medicine at Cambridge University and St
Bartholomew’s Hospital in London. After experience in general medicine in Nottingham, he moved to Edinburgh and
trained in Clinical Oncology. He spent a year as a French Government and EEC research fellow at Institut Gustave
Roussy in Paris. He was subsequently appointed consultant in Clinical Oncology in Sheffield. He returned to Edinburgh
in 1992 where he is a consultant in Clinical Oncology specialising in breast cancer.
His research interests are in adjuvant trials of radiotherapy for older patients with breast cancer and the development
of biosensors to optimise radiotherapy for solid hypoxic tumours. He is Chief Investigator of the BIG 2-04 MRC/EORTC
SUPREMO trial, the PRIME 2 trial and co-PI of the EPSRC funded IMPACT project
(www.impact.eng.ed.ac.uk) on
implantable microsystems for personalised anti-cancer therapy. He has edited two editions of Walter and Miller’s
Textbook of Radiotherapy and published over 100 articles. He is a past President of the British Oncological Association.
Marco Ladetto
The speaker biography has not been received at the time of publication.
Speaker Abstract(s): S36
Alessandra Larocca
A. O. Città della Salute e della Scienza di Torino, P.O. Molinette, Divisione Universitaria Ematologia 1, Torino, Italy
Alessandra Larocca, MD, PhD is a Consultant physician of the Division of Hematology at the Department of Hematology-
Oncology of the University Hospital Città della Salute e della Scienza, Torino, Italy.
She studied Medicine at the University of Milano (1996–2001), and completed her residency in Hematology at the same
institution (2001–2005).
In 2014 she obtained her PhD in Pathology and Experimental Oncology at the University of Torino. She is coordinating and
working on the design and development of clinical trials for multiple myeloma developed in the Department of Hematology.
She is author and co-author of papers and books published in peer-reviewed journals. Her interest is in multiple myeloma
and its treatment including new drugs, with special focus on clinical trials and treatment of elderly patients.
Speaker Abstract(s): S28
Trine Lembrecht Jørgensen
Odense University Hospital, Oncology, Odense, Denmark
Trine Lembrecht Jørgensen, MD, PhD has been involved in geriatric cancer research since 2009. She is a medical doctor
training to be a clinical Oncologist and finished her PhD in 2012. She is currently training part time to be a clinical
oncologist while doing postdoctoral research in the Academy of Geriatric Cancer Research, AgeCare.
Speaker Abstract(s): S29